1+ day, 45+ min ago  (186+ words) " Explore our new Psychedelic Readout Tracker. Stay abreast of psychedelic drug development readouts using our tracker, which provides row-by-row detail and links to Psychedelic Alpha's coverage. " " Readout delivered. The company has not stated clearly whether it will progress the candidate....

1+ week, 3+ day ago  (1587+ words) Explore our " Q1 2026 Psychedelic Pipeline Bullseye Charts. "We have a huge potential for doing novel, groundbreaking work by looking at synaptic density'a molecular target that has recently become available for in vivo imaging. This hasn't really been exploited yet, but'seems to…...

6+ day, 23+ hour ago  (312+ words) Explore our " Q1 2026 Psychedelic Pipeline Bullseye Charts. Welcome to our first P+ Quarterly Briefing! Every three months, our Founder & Editor Josh Hardman will walk you through major developments from the prior quarter across drug development, policy and regulatory, science and academia,…...

1+ week, 5+ day ago  (439+ words) To provide the best experience, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or…...

2+ week, 1+ day ago  (243+ words) Explore our " Q1 2026 Psychedelic Pipeline Bullseye Charts. Dr. Brian Barnett is a staff psychiatrist at Cleveland Clinic's Center for Behavioral Health and the Clinical Director of the Cleveland Clinic Psychiatric Treatment-Resistance Program. He has served as principal investigator on clinical trials…...

2+ week, 5+ day ago  (208+ words) Explore our " Q1 2026 Psychedelic Pipeline Bullseye Charts. My last U. S. -focused dispatch, The View from D. C. published in December, reported significant tumult across the regulatory apparatus and within the psychedelics advocacy realm. Beneath the noise, however, I observed a quiet confidence that multiple…...

3+ week, 1+ day ago  (262+ words) Explore our " Q1 2026 Psychedelic Pipeline Bullseye Charts. In this conversation, Nemeroff talks about how that ibogaine programme came together and what his group hopes to learn, as well as a broader look at the centre's psychedelic research portfolio, unanswered questions he…...

4+ week, 1+ hour ago  (1411+ words) To provide the best experience, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or…...

4+ week, 2+ day ago  (220+ words) Such discussions were initially the result of inbound interest in the aftermath of the'Abb Vie-Gilgamesh'transaction, with unsuccessful bidders from that deal apparently on the hunt for another short-acting psychedelic candidate. Having been approached by several pharmaceutical companies, the sources told…...

1+ mon, 5+ day ago  (143+ words) Sign-in or join P+to watch this video" Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. " Regular Bulletins covering key topics and trends in the psychedelics space…...